Pillstats
Rx only · Capsule, Delayed Release · Oral

Pancrelipase

Brands: Creon · Pertzye · Pancrelipase Amylase + Pancrelipase Lipase + Pancrelipase Protease

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US6 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)743
US makers2 labelers
Packages18
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.28$2.56$3.84$5.12Dec 2025May 2026Jul 2026
$4.444
Latest avg · Jul 22, 2026
+156%
Since Dec 17, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.7K3.4K5.0K6.7K2025 Q12025 Q22025 Q32025 Q42026 Q1
5.4K
Rx · 2026 Q1
1.8M
Units dispensed
-1%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Digestive Care, Inc.unknown14SUPPLYING
AbbVie Inc.unknown4SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.